Non-interventional Study on Oral Contraception Not Containing Ethinylestradiol (EE) to Assess Continuation Rates and Satisfaction
NCT ID: NCT01200186
Last Updated: 2015-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3258 participants
OBSERVATIONAL
2010-10-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
NCT00206583
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289
Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects
NCT01638910
Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive
NCT00185224
Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens
NCT00805415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
EV/DNG (Qlaira, BAY86-5027)
At the discretion of the attending physician
Group 2
Progestin Only Pills
At the discretion of the attending physician
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EV/DNG (Qlaira, BAY86-5027)
At the discretion of the attending physician
Progestin Only Pills
At the discretion of the attending physician
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who used ethinylestradiol containing oral contraceptives for at least the three preceding months before the study
* Women who decided to start Qlaira® or a Progestin Only Pill. The prescription of the hormonal contraceptive is made at the discretion of the attending physician and has to be documented
Exclusion Criteria
* Women who are breast-feeding
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bayer Study Director
Role: STUDY_DIRECTOR
Bayer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Many Locations, , Czechia
Many Locations, , France
Many Locations, , Germany
Many Locations, , Greece
Many Locations, , Hungary
Many Locations, , Israel
Many Locations, , Italy
Many Locations, , Russia
Many Locations, , Slovakia
Many Locations, , Sweden
Many Locations, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QL0901
Identifier Type: OTHER
Identifier Source: secondary_id
15217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.